Related references
Note: Only part of the references are listed.New therapeutic aspects of steroidal cardiac glycosides: the anticancer properties of Huachansu and its main active constituent Bufalin
Chien-shan Cheng et al.
CANCER CELL INTERNATIONAL (2019)
Simultaneous Determination of Bufalin and Its Nine Metabolites in Rat Plasma for Characterization of Metabolic Profiles and Pharmacokinetic Study by LC-MS/MS
Wenlong Wei et al.
MOLECULES (2019)
BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survival
Erinna F. Lee et al.
CELL DEATH & DISEASE (2019)
Bufalin inhibits human breast cancer tumorigenesis by inducing cell death through the ROS-mediated RIP1/RIP3/PARP-1 pathways
Yanlan Li et al.
CARCINOGENESIS (2018)
Bufalin suppresses colorectal cancer cell growth through promoting autophagy in vivo and in vitro
Zhe Pan et al.
RSC ADVANCES (2018)
Bufalin induces apoptosis in vitro and has Antitumor activity against human lung cancer xenografts in vivo
Shin-Hwar Wu et al.
ENVIRONMENTAL TOXICOLOGY (2017)
Effects of bufalin on the mTOR/p70S6K pathway and apoptosis in esophageal squamous cell carcinoma in nude mice
Yao Liu et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2017)
The Diagnosis and Treatment of Prostate Cancer A Review
Mark S. Litwin et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Blocking autophagy enhances the pro-apoptotic effect of bufalin on human gastric cancer cells through endoplasmic reticulum stress
Hongyan Zhao et al.
BIOLOGY OPEN (2017)
Prospective investigation of risk factors for prostate cancer in the UK Biobank cohort study
Aurora Perez-Cornago et al.
BRITISH JOURNAL OF CANCER (2017)
DNA topoisomerase-targeting chemotherapeutics: what's new?
Selma M. Cuya et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
Cancer Statistics in China, 2015
Wanqing Chen et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Biodegradable brush-type copolymer modified with targeting peptide as a nanoscopic platform for targeting drug delivery to treat castration-resistant prostate cancer
Tao Liu et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2016)
Bufalin inhibits pancreatic cancer by inducing cell cycle arrest via the c-Myc/NF-κB pathway
Xia Liu et al.
JOURNAL OF ETHNOPHARMACOLOGY (2016)
Anticancer Effect of Fucoidan on DU-145 Prostate Cancer Cells through Inhibition of PI3K/Akt and MAPK Pathway Expression
Gang-Sik Choo et al.
MARINE DRUGS (2016)
A Comparative Evaluation of Hydroxycamptothecin Drug Nanorods With and Without Methotrexate Prodrug Functionalization for Drug Delivery
Fuqiang Guo et al.
NANOSCALE RESEARCH LETTERS (2016)
A Comparative Evaluation of Hydroxycamptothecin Drug Nanorods With and Without Methotrexate Prodrug Functionalization for Drug Delivery
Fuqiang Guo et al.
NANOSCALE RESEARCH LETTERS (2016)
Optimized combinations of bortezomib, camptothecin, and doxorubicin show increased efficacy and reduced toxicity in treating oral cancer
Xianting Ding et al.
ANTI-CANCER DRUGS (2015)
Targeting of Topoisomerase I for Prognoses and Therapeutics of Camptothecin-Resistant Ovarian Cancer
Yu-Chieh Lee et al.
PLOS ONE (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Expression of Proliferating Cell Nuclear Antigen (PCNA) in Oral Submucous Fibrosis: An Immunohistochemical Study
Roopavathi Keshav et al.
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH (2015)
Bufalin Is a Potent Small-Molecule Inhibitor of the Steroid Receptor Coactivators SRC-3 and SRC-1
Ying Wang et al.
CANCER RESEARCH (2014)
Bufalin-Inhibited Migration and Invasion in Human Osteosarcoma U-2 OS Cells Is Carried Out by Suppression of the Matrix Metalloproteinase-2, ERK, and JNK Signaling Pathways
Fu-Shin Chueh et al.
ENVIRONMENTAL TOXICOLOGY (2014)
Bufalin attenuates the stage and metastatic potential of hepatocellular carcinoma in nude mice
Zhou-Ji Zhang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Prostate cancer in young men: an important clinical entity
Claudia A. Salinas et al.
NATURE REVIEWS UROLOGY (2014)
Bufalin inhibits the differentiation and proliferation of human osteosarcoma cell line hMG63-derived cancer stem cells
Yuewen Chang et al.
TUMOR BIOLOGY (2014)
Bufalin exerts antitumor effects by inducing cell cycle arrest and triggering apoptosis in pancreatic cancer cells
Meiying Li et al.
TUMOR BIOLOGY (2014)
Bufalin, a component in Chansu, inhibits proliferation and invasion of hepatocellular carcinoma cells
Dong-Ze Qiu et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2013)
Anticancer Effects of Bufalin on Human Hepatocellular Carcinoma HepG2 Cells: Roles of Apoptosis and Autophagy
Qing Miao et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Bufalin prevents the migration and invasion of T24 bladder carcinoma cells through the inactivation of matrix metalloproteinases and modulation of tight junctions
Su Hyun Hong et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Deregulation of Apoptotic Factors Bcl-xL and Bax Confers Apoptotic Resistance to Myeloid-derived Suppressor Cells and Contributes to Their Persistence in Cancer
Xiaolin Hu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Bufalin Induces Lung Cancer Cell Apoptosis via the Inhibition of PI3K/Akt Pathway
Zhitu Zhu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Effect of endocrine treatment on voiding and prostate size in men with prostate cancer: A long-term prospective study
Louise L. Klarskov et al.
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY (2012)
Bufalin enhances the antitumor effect of gemcitabine in pancreatic cancer
Ying Chen et al.
ONCOLOGY LETTERS (2012)
Differential roles of Trk and p75 neurotrophin receptors in tumorigenesis and chemoresistance ex vivo and in vivo
Muriel Bassili et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
Hypertonicity-induced Mitochondrial Membrane Permeability in Renal Medullary Interstitial Cells: Protective Role of Osmolytes
Li Zhang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2010)
Current management of castrate-resistant prostate cancer
S. J. Hotte et al.
Current Oncology (2010)
Effects of bufalin on the proliferation of human lung cancer cells and its molecular mechanisms of action
Yongtao Jiang et al.
CYTOTECHNOLOGY (2010)
p53 at a glance
Colleen A. Brady et al.
JOURNAL OF CELL SCIENCE (2010)
The Role of Mitochondria in Apoptosis
Chunxin Wang et al.
ANNUAL REVIEW OF GENETICS (2009)
DNA Topology and Topoisomerases
Joseph E. Deweese et al.
BIOCHEMISTRY AND MOLECULAR BIOLOGY EDUCATION (2009)
The tumour suppressor Pdcd4: recent advances in the elucidation of function and regulation
Brigitte Lankat-Buttgereit et al.
BIOLOGY OF THE CELL (2009)
Watching the watcher: regulation of p53 by mitochondria
Aaron K. Holley et al.
FUTURE ONCOLOGY (2009)
TNFSF10 (TRAIL), a p53 target gene that mediates p53-dependent cell death
Kageaki Kuribayashi et al.
CANCER BIOLOGY & THERAPY (2008)
Apoptotic signaling in bufalin- and cinobufagin-treated androgen-dependent and -independent human prostate cancer cells
Ching-Han Yu et al.
CANCER SCIENCE (2008)
Key role of topoisomerase I inhibitors in the treatment of recurrent and refractory epithelial ovarian carcinoma
Stephanie L. Wethington et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2008)
Mitochondrial potassium channel Kv1.3 mediates Bax-induced apoptosis in lymphocytes
Ildiko Szabo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Anti-tumor activities and apoptosis-regulated mechanisms of bufalin on the orthotopic transplantation tumor model of human hepatocellular carcinoma in nude mice
Ke-Qi Han et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Coping with stress: multiple ways to activate p53
H. F. Horn et al.
ONCOGENE (2007)
Mitochondria as the target of the pro-apoptotic protein Bax
Ernine Er et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2006)
Bufalin influences the repair of X-ray-induced DNA breaks in Chinese hamster cells
N Pastor et al.
DNA REPAIR (2003)
The topoisomerase I inhibitor topotecan increases the sensitivity of prostate tumor cells to TRAIL/Apo-2L-induced apoptosis
TS Griffith et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2003)
Wnt-1 signaling inhibits apoptosis by activating β-catenin/T cell factor-mediated transcription
SQ Chen et al.
JOURNAL OF CELL BIOLOGY (2001)
Share Paper
